Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry

被引:651
作者
Zhang, Ling [1 ]
Peng, Xin-Mei [1 ]
Damu, Guri L. V. [1 ]
Geng, Rong-Xia [1 ]
Zhou, Cheng-He [1 ]
机构
[1] Southwest Univ, Sch Chem & Chem Engn, Lab Bioorgan & Med Chem, Chongqing 400715, Peoples R China
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
imidazole; anticancer; antifungal; antineuropathic; antihistaminic; MAP KINASE INHIBITORS; TOPOISOMERASE-I INHIBITORS; HISTONE DEACETYLASE INHIBITORS; POTENTIAL ANTIMICROBIAL AGENTS; VITRO LEISHMANICIDAL ACTIVITY; SELECTIVE CYP11B1 INHIBITORS; COMBRETASTATIN A-4 ANALOGS; HEME OXYGENASE INHIBITION; HISTAMINE H-4 RECEPTOR; STRUCTURE-BASED DESIGN;
D O I
10.1002/med.21290
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Imidazole ring is an important five-membered aromatic heterocycle widely present in natural products and synthetic molecules. The unique structural feature of imidazole ring with desirable electron-rich characteristic is beneficial for imidazole derivatives to readily bind with a variety of enzymes and receptors in biological systems through diverse weak interactions, thereby exhibiting broad bioactivities. The related research and developments of imidazole-based medicinal chemistry have become a rapidly developing and increasingly active topic. Particularly, numerous imidazole-based compounds as clinical drugs have been extensively used in the clinic to treat various types of diseases with high therapeutic potency, which have shown the enormous development value. This work systematically gives a comprehensive review in current developments of imidazole-based compounds in the whole range of medicinal chemistry as anticancer, antifungal, antibacterial, antitubercular, anti-inflammatory, antineuropathic, antihypertensive, antihistaminic, antiparasitic, antiobesity, antiviral, and other medicinal agents, together with their potential applications in diagnostics and pathology. It is hoped that this review will be helpful for new thoughts in the quest for rational designs of more active and less toxic imidazole-based medicinal drugs, as well as more effective diagnostic agents and pathologic probes.
引用
收藏
页码:340 / 437
页数:98
相关论文
共 558 条
  • [1] Synthesis and biological evaluation of imidazolylmethylacridones as cytochrome P-450 enzymes inhibitors
    Abadi, Ashraf H.
    Abou-Seri, Sahar M.
    Hu, Qingzhong
    Negri, Matthias
    Hartmann, Rolf W.
    [J]. MEDCHEMCOMM, 2012, 3 (06) : 663 - 666
  • [2] Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Abdel-Wahab, Bakr F.
    Awad, Ghada E. A.
    Badria, Farid A.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (05) : 1505 - 1511
  • [3] Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides
    Aboraia, Ahmed S.
    Yee, Sook Wah
    Gomaa, Mohamed Sayed
    Shah, Nikhil
    Robotham, Anna C.
    Makowski, Bart
    Prosser, David
    Brancale, Andrea
    Jones, Glenville
    Simons, Claire
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 4939 - 4946
  • [4] Synthesis and Anti-Candida Potential of Certain Novel 1-[(3-Substituted-3-phenyl)propyl]-1H-imidazoles
    Aboul-Enein, Mohamed Nabil
    El-Azzouny, Aida Abd El-Sattar
    Attia, Mohamed Ibrahim
    Saleh, Ola Ahmed
    Kansoh, Amany Lotfy
    [J]. ARCHIV DER PHARMAZIE, 2011, 344 (12) : 794 - 801
  • [5] Role of the Hydrogen Bonding Heteroatom-Lys53 Interaction between the p38α Mitogen-Activated Protein (MAP) Kinase and Pyridinyl-Substituted 5-Membered Heterocyclic Ring Inhibitors
    Abu Thaher, Bassam
    Koch, Pierre
    Schattel, Verena
    Laufer, Stefan
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2613 - 2617
  • [6] AEWSKA D, 2009, BIOORG MED CHEM LETT, V19, P6682
  • [7] The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives
    Agelis, George
    Resvani, Amalia
    Durdagi, Serdar
    Spyridaki, Katerina
    Tumova, Tereza
    Slaninova, Jitina
    Giannopoulos, Panagiotis
    Vlahakos, Demetrios
    Liapakis, George
    Mavromoustakos, Thomas
    Matsoukas, John
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 358 - 374
  • [8] An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies
    Agelis, George
    Roumelioti, Panagiota
    Resvani, Amalia
    Durdagi, Serdar
    Androutsou, Maria-Eleni
    Kelaidonis, Konstantinos
    Vlahakos, Demetrios
    Mavromoustakos, Thomas
    Matsoukas, John
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (09) : 749 - 758
  • [9] 1-[(2-Arylthiazol-4-yl)methyl]azoles as a New Class of Anticonvulsants: Design, Synthesis, In vivo Screening, and In silico Drug-like Properties
    Ahangar, Nematollah
    Ayati, Adile
    Alipour, Eskandar
    Pashapour, Arsalan
    Foroumadi, Alireza
    Emami, Saeed
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (05) : 844 - 852
  • [10] Synthesis and Biochemical Evaluation of a Range of 2-, 3-and 4-Substituted Derivatives of Benzyl Imidazole-Based Compounds as Probes of the Active Site of 17α-hydroxylase/17,20-Lyase (P45017α)
    Ahmed, Sabbir
    Shahid, Imran
    Bhatti, Kishore K.
    Lee, Wai-Yee
    Owen, Caroline P.
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (07) : 524 - 530